शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSENG Industries Ltd-$· Healthcare ServicesHighPositive
Announced Tue, 27 May, 2025 · 16:31 IST

Outcome of Board Meeting held for consideration and approval of Audited Financial Results for Quarter and year ended 31st March, 2025 and Recommendation of Final Dividend subject to approval ....

Net loss reportedRevenue declinedResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹165.20
prior close
₹155.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-0.3% vs market
Healthcare Service Provider peers, median of 23sector+0.6%-0.6% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.6 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.3
10m
+3.2
15m
+3.2
30m
+6.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0+0.3-0.3+0.6-0.6
Next day
+2.2+0.7+1.6-0.1+2.4
2d
-3.1+1.0-4.1-0.4-2.8
3d
-2.8+1.1-3.9-0.6-2.3
4d
-1.5+0.8-2.2-0.4-1.0
5d
-3.2+1.3-4.5-0.1-3.1
1w
-3.1+1.7-4.8+0.3-3.4
15d
-2.8+1.5-4.3+2.1-4.9
1m
-5.6+4.0-9.6-0.1-5.4
2m
-6.2+1.8-8.0+8.6-14.8
3m
-12.8-1.0-11.9+11.8-24.6
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

N G Industries Ltd's Board approved audited standalone financial results for Q4 and FY ended 31 March 2025, with an unmodified (clean) opinion from statutory auditor M.R. Singhwi & Co. Full-year Profit After Tax rose sharply to Rs. 773.95 lakh (up ~54% from Rs. 503.37 lakh in FY24), and EPS doubled to Rs. 23.10 from Rs. 15.02. However, Q4 standalone results swung to a loss of Rs. 243.41 lakh (vs. profit of Rs. 193.97 lakh last year), and core net sales declined slightly to Rs. 1,654.68 lakh from Rs. 1,688.23 lakh. A large chunk of the full-year profit (over Rs. 702 lakh) came from gains on sale of investments rather than operations. The Board recommended a final dividend of Rs. 3.50 per share (35%).

Likely market impact

Short-term: solid full-year PAT growth and a 35% dividend may support the stock, but the Q4 loss and reliance on investment gains to drive earnings warrant caution. Long-term: the clean audit opinion and unchanged auditor provide stability, though investors should watch whether core operations can sustain profitability without investment gains.